Dx4Life is a company headquartered in Sweden. Brouky records 1 investor associated with the company.
Dx4Life develops a genetic test to guide hormone treatment for IVF, aiming to increase the success rate of fertility treatments by identifying the optimal hormone regimen for each patient.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.